Style | Citing Format |
---|---|
MLA | Arabzadeh AA, et al.. "Efficacy of Heparin–Vancomycin–Amikacin Combination Lock in Preventing Catheter-Related Infections in Haemodialysis Patients: A Double-Blind Randomized Clinical Trial." Infection Prevention in Practice, vol. 7, no. 2, 2025, pp. -. |
APA | Arabzadeh AA, Iranikia M, Pourfarzi F, Shahrami B, M Kebar S (2025). Efficacy of Heparin–Vancomycin–Amikacin Combination Lock in Preventing Catheter-Related Infections in Haemodialysis Patients: A Double-Blind Randomized Clinical Trial. Infection Prevention in Practice, 7(2), -. |
Chicago | Arabzadeh AA, Iranikia M, Pourfarzi F, Shahrami B, M Kebar S. "Efficacy of Heparin–Vancomycin–Amikacin Combination Lock in Preventing Catheter-Related Infections in Haemodialysis Patients: A Double-Blind Randomized Clinical Trial." Infection Prevention in Practice 7, no. 2 (2025): -. |
Harvard | Arabzadeh AA et al. (2025) 'Efficacy of Heparin–Vancomycin–Amikacin Combination Lock in Preventing Catheter-Related Infections in Haemodialysis Patients: A Double-Blind Randomized Clinical Trial', Infection Prevention in Practice, 7(2), pp. -. |
Vancouver | Arabzadeh AA, Iranikia M, Pourfarzi F, Shahrami B, M Kebar S. Efficacy of Heparin–Vancomycin–Amikacin Combination Lock in Preventing Catheter-Related Infections in Haemodialysis Patients: A Double-Blind Randomized Clinical Trial. Infection Prevention in Practice. 2025;7(2):-. |
BibTex | @article{ author = {Arabzadeh AA and Iranikia M and Pourfarzi F and Shahrami B and M Kebar S}, title = {Efficacy of Heparin–Vancomycin–Amikacin Combination Lock in Preventing Catheter-Related Infections in Haemodialysis Patients: A Double-Blind Randomized Clinical Trial}, journal = {Infection Prevention in Practice}, volume = {7}, number = {2}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Arabzadeh AA AU - Iranikia M AU - Pourfarzi F AU - Shahrami B AU - M Kebar S TI - Efficacy of Heparin–Vancomycin–Amikacin Combination Lock in Preventing Catheter-Related Infections in Haemodialysis Patients: A Double-Blind Randomized Clinical Trial JO - Infection Prevention in Practice VL - 7 IS - 2 SP - EP - PY - 2025 ER - |